drugset / Trial / NCT00540709

PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro

NCT00540709 ↗

Phase 4 Completed 58 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

Whether a once-daily basal injection of insulin glargine with mealtime injections of insulin lispro achieves equivalent glycaemic control (HbA1c) to administration of insulin lispro by continuous subcutaneous insulin infusion in Type 1 diabetic patients.

Timeline

Start
2002-11
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic — —

Indications